The lower end of the AIM market seems to be littered with small companies that haven’t made any real progress over the years, in terms of shareholder returns, and I’m often left wondering what the point of them being listed is, given the additional costs that involves.
Does anyone know this Ian Roy Duncan? He seems unhinged but I receive emails, like the one I read out in this podcast, more or less every day. Ian owns shares in Supply@ME Capital (SYME) and I discuss that particular Norfolk and why you have to be truly thick as two short planks, as Ian is, to own after today’s news. I also look at Verditek (VDTK), UK Oil & Gas (UKOG), Red Rock Resources (RRR), Zenith Energy (ZEN) – for whom I have a question – Avacta (AVCT) and ValiRX (VAL) where the valuation, even after today’s fall, looks bonkers after trial data which I discuss and analyse.
Having failed to cure cancer, almost out of cash ValiRx (VAL) needs another story to ramp to allow its low-life brokers Peterhouse to get another discounted placing away to its spivvy flipper mates. Ahoy is that a bandwagon I see in the distance? Yes it is the Covid Express. Time to jump aboard.
I am absolutely exhausted. Recording videos is pretty draining. You have to remember not to pick your nose and to be alert at all times and right now I am recording four or five a day plus bearcast. That is all for the ShareProphets Shares Conference where, I promise, you will be dazzled by the content so BOOK YOUR TICKET NOW HERE!!! In today's podcast I discuss Big Sofa (BST), Shell (RDSB), ValiRx (VAL), Catenae (CTEA) and James "Dracula" Parsons, Cheryl Cole and Ascent Resources (AST). Suffice to say only one of that trio excites me in any way.
Here we go again. Grace Slick could have been thinking of Peterhouse’s antics – as exposed here - when penning her most famous number “When logic and proportion, Have fallen sloppy dead” Exactly. So what is the ValiRx (VAL) white rabbit?
A bit of a storm has been blowing up at AIM-listed cash-hungry biotech dog ValiRx (VAL). A General Meeting had been proposed for shareholders to agree to the issue of yet more confetti in order to keep the Grim Reaper from the door but the government decreed Covid-19 lockdown intervened and the meeting could not happen. Yesterday the GM was reconvened with shareholders unable to attend or vote – and two of the three resolutions were passed. But what of legality?...
This is all to do with my own panic shopping but what it told me about how others are behaving. If folks think that most consumers continue to act as if nothing is wrong, think again. Then I look at Future (FUTR) which i don't believe as it issues a trading statement, round two of beer and popcorn at Iofina (IOF) as the great Brexit bad boy Arron Banks makes his move, French Connection (FCCN) and ValiRx (VAL) botb of which look pretty fecked.
hey what better way to mark International Women's day than to hear an overpaid BBC nobody interview someone who says she is " A self-confessed believer in the human spirit, she is ‘ridiculously and overwhelmingly happy with the opportunities that she has to develop and how she can play into the amazing world that we live in." Yup, you know who is back. Elsewhere in this podcast I discuss Versarien (VRS), whose Nomad DID resign, ValiRx (VAL), Sound Energy (SOU), Petra Diamonds (PDL), Novacyt (NCYT), Nostra Terra (NTOG) and Laura Ashley (ALY). I also ask you to be generous and give to a great cause today HERE
In today's podcast I discuss freedom of expression with reference to Alistair Stewart, Andrew Monk, Schroders and a whore's drawers. I look at ValiRx (VAL), the joke that is NEX Exchange Regulation, Oracle Power (ORCP), Andalas Energy (ADL) and Haydale Graphene (HAYD). Finally I defend No Gold ( please donate to the Rogue Bloggers for Woodlarks old chap, HERE) and report back on my Optibiotix (OPTI), Slimbiome weight loss programme.
When I first commented on AIM-listed cancer drug developer ValiRx (VAL) back in 2016 the shares had just seen a pump’n’dump which pushed the stock up to 21p before a placing at just 12p. Now the stock is just 0.1p and on a market cap of £0.9m (source: ADVFN): never mind the 90% club, this is a fully paid up member of the 99% club. And now we have a placing for just £200,000 gross…..and Broker number three joins the fray, although as Tom Winnifrith points out the RNS will have to be reissued. How on earth can you justify paying three broker retainers for a company worth less than a million pounds?
I do not wish to be seen as a pedant but an RNS statement is meant to be, you know, like, er, accurate. And thus as an upstanding member of the AIM Casino community I have penned a quick email to my pal Liam Murray at Nomad Cairn Financial about today's RNS from ValirX (VAL) which appears to fail the accuracy test. I write.
I am procrastinating ahead of a 24 mile training walk in the Grim North as the wind blows hard and the rain tips it down. As you think of my suffering please please donate now HERE. In consider the 3Xs in light of today's Pathfinder (PFP) scoop. I apologise to Peter Greensmith, he is not the knobhead in the Bidstack (BIDS) affair and indeed not a knobhead at all. I name the real knobheads and have another scoop on the company showing how firms like Optiva make AIM a disorderly market with their slimeball behaviour. Finally I look at yesterday's financing by ValiRx (VAL) which looks like a bad deal in so many ways.
In Today's bearcast I look at ValiRx (VAL) whose CEO I actually like and at my portfolio, am I worried no? I comment on what Nigel Somerville is up to today which is bad news indeed for Larry Cummins of Black Cactus and Milestone (MSG) infamy. I look at Ambrian (AMBR), The People's Operator (TPOP), Magnolia Petroloeum (MAGP) and how it legged AIM over yet again, at Physiomics (PYC) and finally in depth at Lombard Risk Management (LRM) where the curse of Phil "InterX" Crawford looks set to strike again.
Perhaps ValiRx (VAL) should be making a statement about events at Valiseek?
In this video from the storming success that was the 2017 UK Investor Show, Satu Vainikka of Valirx (VAL) is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.
Having seen a cracking 23 dodgy RNSs released on the last trading day before Christmas as bad news was buried in last-minute Christmas shopping and even then a few were slipped out hours after the markets closed, the totally unbiased adjudication of the Global Shorting Conspiracy has reviewed the releases on the last trading day of 2016 for attempts at burying bad news. You were asked how many there would be, and we have a winner. But first, a round-up of the missives concerned.
I’ve been following the antics of Sanderson Capital Partners for a while now and yesterday’s latest shocking funding deal with Eurasia Mining (EUA) has tipped me over the edge and forced me to write.
I was delighted to read this morning’s RNS from AIM-listed cancer-buster ValiRx (VAL): it has ditched the value-destroying funding package with Bracknor. About time too, this has been a disaster for the share price ever since it was announced back in March. With the shares having crashed from 12.5p the day before the package was announced to the current 6.875p (last seen) the damage has been horrific.
I highlighted yesterday that it seemed to me that the failure of shareholders in AIM-listed cancer-buster ValiRx to pass a special resolution at last week’s AGM to disapply pre-emption rights cast a bit of a shadow over the company’s funding arrangements. In a move straight out of the EU rulebook on democracy, shareholders are to be given the (ahem) opportunity to vote again in the hope of coming up with the right answer this time.
Shareholders in AIM-listed cancer-buster ValiRx (VAL) rejected a disapplication of pre-emption rights special resolution at the AGM held last Monday. The company said a further announcement would follow “in due course” but since then there has been silence. But it seems that there might be a few implications for the financing of the company going forward.
This morning saw AIM-listed ValiRx (VAL) appoint Beaufort Securities as Joint Broker. This coincided with a quarterly update RNS full of good news and Beaufort included a generous write-up in today’s morning note, with a “speculative buy” rating. All jolly good, but I fear that yet more errors have been made by the company.
After-hours (natch) yesterday AIM-listed biotech ValiRx (VAL) released an RNS announcing the drawdown of the second £500,000 tranche (of up to eight) of its convertible death spiral funding package with Bracknor. We were also told that half of it had already been converted, with reference made to the terms set out in an RNS of 21 March 2016. But the numbers simply don’t add up – oh, and the company had now admitted that associated warrants will have to be approved by shareholders.
The fourth Dragon's Den session at UK Investor show saw myself (Tom Winnifrith), Brian Kinane and Steve Moore each invest £1,000 in shares. Our choice of where to invest was ValiRx (VAL), Jubilee Platinum (JLP), Kibo Mining (KIBO) or Ariana Resources (AAU). Enjoy.
And now for a video from the biotech boss who I have sworn to be nice to, Dr Satu Vainikka of ValiRx (VAL) presenting at UK Investor Show. Enjoy.
AIM-listed ValiRx (VAL) operates in the biotech space, developing cancer drugs. I’ve been pretty beastly in previous pieces (see HERE) but I am pleased to note that the company has seen fit to address the questions asked over Companies House filings. As pointed out HERE they were indeed wrong and they have now been corrected. Good news. My hope is that the questions over the Bracknor funding deal will now be addressed.
After-hours last night (5pm) AIM-listed ValirX (VAL) announced a second batch of loan conversions under its £4 million (except it is up to £8.6 million) funding deal with Bracknor. It was at just 7.4p so it is no great surprise that the shares are down at 8.625p mid (last seen) having closed last night at 9.25p. But then there are those warrants….does anyone have the slightest Scooby of what’s going on there from last night’s announcement?
On 21 March this year, AIM-listed ValiRx (VAL) announced a convertible loan facility with Bracknor Fund Ltd. It was announced that the company could draw down up to £4 million in tranches of £500,000. But it seems that some of the information given was either wrong or just missing, not to mention a small problem of share issuance authorities which look to be insufficient to seal the deal. Having had no reply to two emails sent to the company, I am assuming that the conclusions I have come to are correct. It is not pretty.
Two positive-looking RNSs, one each on 9 Feb and 16 Feb saw shares in AIM-listed ValiRx (VAL) shifting about sharply. On 9 Feb the shares shot up from a previous close of 15p and peaking at 18.25p before topping out at 21p the following day. Then Tuesday's news saw the shares close down at 13.25. And lo and behold yesterday we had a keep-the-lights on placing to raise £0.5 million at just 12p a share.
Yes I have indeed done just that, or I think I have. The olive harvest saga continues and the snow has started on the mountains above the Greek Hovel, pictures later. In this podcast I look at Jabba The Hutt ramping Afriag (AFRI) and warn you what will happen next. Then a comment on LGO Energy (LGO) before heading onto PeerTV (PTV) and - in an unusual manner - I cover ValiRx (VAL). You see Satu I am a man of my word, Halosource (HALO) gets "the treatment" as does Gary Newman for buying into corporate bullshit speak. Then it is onto Photosntar Led (PSL), Fitbug (FITB) and finally InternetQ (INTQ).
The annual ritual is complete. The Mrs and I have photographed my morbidly obese three legged cat Oakley in his Christmas hat and even Tara played her part posing in the hat and in a stocking. And thus our rather un-Christian cards are now in production. Awway from that I have a long look at Slater & Gordon (SGH) where the management has just allowed the bears a chance to sell even more shares. Jabba The Hutt stocks Solo (SOLO) and LGO Energy (LGO) get a mention as does Aureus Mining (AUE) with its hugely discounted placing. Alba (ALBA) is clearly lining up its next confetti issue and I comment on that as well as Blur (BLUR), Outsourcery (OUT), Wandisco (WAND), Plant Health Care (PHC), Gulf Keystone (GKP) and NAHL (NAH), Finally I commend the CEO of ValiRx (VAL) who attended Gold & Bears on Saturday and was incredibly poilite. Memo to TW. I will be less beastly to her in 2016.
If you want me to analyse a stock for you just drop me a line at firstname.lastname@example.org - Today I look at shares in Cannacord Genuity (CF.), Globo (GBO), Valirx (VAL), setting share price targets for all three stocks.
Forget all the jam tomorrow garbage from serial cash burning biotech loser ValiRX (VAL) the half year report out this morning is a dog’s dinner. Look at the numbers.
Jeremy Corbyn was right not to sing the Natonal Anthem and its a poor song anyway - that was my earlier podcast today which you can hear HERE. In terms of the markets it is all my Christmases at once - a chance to comment on friends including the greedy bastards who run Vislink (VLK), fraudster Rob Terry, Daniel Stewart (DAN), Imaginitik (IMTK), ValiRx (VAL), Motive TV (MTV) and also on SeaEnergy (SEA) and Avanti Communications (AVN). Then there is comment on the bad AGM result at Hotel Corp (HCP) - victory for the crony capitalist bastards on the board - all that is wrong about AIM. And I start with words of praise for my pal Jim Mellon noting events at Copper Development (CDC) and also at Glencore (GLEN) - is this a Burmah Castrol moment?
This is the first podcast using the Audioboom (BOOM) platform - if it sounds rubbish/does not arrive blame the IT klutz me not Rob Proctor. In today's offering I look at Haike Chemical (HAIK), Jiasen (JSI), Camkids (CAMK), ValirX (VAL) and a few other matters en passant.
If you want me to analyse a stock for you just drop me a line at email@example.com - Today I look at shares in Feedback (FDBK), MySale (MYSL) and Valirx (VAL) setting a share price target for each.
Featuring Frontera Resources (FRR), Mobilityone (MBO), Sirius Minerals (SXX), Valirx (VAL), XTR Resources (XTR)